2024
|
P/S
|
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous syst... |
|
Invention
|
Multivalent pneumococcal polysaccharide-protein conjugate composition.
An immunogenic compositio... |
2023
|
Invention
|
Formulations for parenteral delivery of compounds and uses thereof.
The present invention provid... |
|
Invention
|
Use of perfusion to enhance production of fed-batch cell culture in bioreactors.
The invention r... |
2022
|
Invention
|
Compositions relating to a mutant clostridium difficile toxin and methods thereof.
In one aspect... |
|
Invention
|
Method for treating gefitinib resistant cancer.
The present invention is directed to methods for... |
|
Invention
|
Antineoplastic combinations with m-tor inhibitor, trastuzumab and/or hki-272.
A combination of t... |
|
Invention
|
Sustained release pharmaceutical compositions.
The present invention provides controlled release... |
2021
|
P/S
|
Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous sy... |
|
Invention
|
Phosphatidylinositol-3-kinase pathway biomarkers.
Methods for treating breast cancer, specifical... |
|
Invention
|
Pneumococcal dosing regimen.
Methods of immunizing older adult subjects against Streptococcus pn... |
|
Invention
|
Process for preparing pneumococcal polysaccharide-protein conjugates.
An immunogenic composition... |
|
P/S
|
Pharmaceutical preparations; Vaccines. |
|
P/S
|
Providing medical information in the field of cardiovascular diseases and the diagnosis and treat... |
2020
|
P/S
|
Pharmaceutical preparations; pre-filled cartridges containing pharmaceutical preparations. mobile... |
|
P/S
|
Vaccines; |
|
P/S
|
Vaccines. |
|
P/S
|
Medical information services. |
|
P/S
|
Providing medical information from a web site; Providing medical information in the field of pneu... |
|
P/S
|
Pharmaceutical preparations; Drugs for medical purposes; Medicines for human purposes; Biological... |
|
P/S
|
Pharmaceutical preparations; pre-filled cartridges containing pharmaceutical preparations. Softwa... |
|
P/S
|
Vaccines for human use. |
|
Invention
|
Sodium chloride solution for drug reconstitution or dilution.
The invention provides methods for... |
|
Invention
|
Streptococcus pneumoniae polysaccharide molecular weight using carbon dioxide. 2. |
|
P/S
|
Pharmaceutical preparations; vaccines for human use. Software and applications for mobile devices... |
|
Invention
|
Process for preparing pneumococcal polysaccharide-protein conjugates. Streptococcus pneumoniae (1... |
2019
|
Invention
|
Compositions relating to a mutant clostridium difficile toxin and methods thereof. C. difficile t... |
|
P/S
|
Pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders |
|
Invention
|
Sustained release pharmaceutical compositions. The present invention provides controlled release ... |
|
Invention
|
Oral formulations and lipophilic salts of methylnaltrexone.
The present invention provides compo... |
|
Invention
|
Neisseria meningitidis orf2086 antigens. Neisseria meningitidis, and methods related thereto. |
|
Invention
|
Pneumococcal dosing regimen. Streptococcus pneumoniae infection are provided. Provided methods co... |
|
Invention
|
Oral formulations and lipophilic salts of methylnaltrexone. The present invention provides compos... |
|
Invention
|
Clostridium difficile toxin and methods thereof. In one aspect, the invention relates to an immun... |
|
P/S
|
Medical information services, namely, providing information related to vaccines for human use; on... |
|
P/S
|
Pharmaceutical preparations for the treatment of a rare protein misfolding disease, namely, amylo... |
|
P/S
|
Pharmaceutical preparations; Human vaccines. |
|
P/S
|
Providing healthcare information; Providing medical information in the field of depression; Provi... |
|
P/S
|
Providing patient advocate services in the field of cardiovascular diseases and disorders |
|
P/S
|
Human vaccine preparations |
|
P/S
|
Pharmaceutical preparations for the treatment of cardiovascular diseases and disorders |
2018
|
Invention
|
Designer osteogenic proteins. The invention relates to novel designer osteogenic proteins having ... |
|
Invention
|
Multivalent pneumococcal polysaccharide-protein conjugate composition. Streptococcus pneumoniae s... |
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of psychiatric diseases, degenerativ... |
|
Invention
|
Anti-5t4 antibodies and uses thereof.
Anti-5T4 antibodies, anti-5T4 antibody/drug conjugates, an... |
2017
|
P/S
|
Pharmaceutical preparations for the treatment of transthyretin amyloidosis; Pharmaceutical prepar... |
|
P/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; pharmaceu... |
|
Invention
|
Processes for the convergent synthesis of calicheamicin derivatives. This invention describes pro... |
|
Invention
|
Clostridium difficile toxin and methods thereof. C. difficile toxin. The mutant toxins may furthe... |
|
Invention
|
Tigecycline compositions and methods of preparation. The present invention relates to novel tigec... |
|
P/S
|
Pharmaceutical preparations for the treatment of cancer. |
|
P/S
|
Pharmaceutical preparations for the treatment of cancer |
|
Invention
|
Osteogenic proteins. The invention relates to novel designer osteogenic proteins having altered a... |
|
Invention
|
Method for controlling streptococcus pneumoniae polysaccharide molecular weight using carbon diox... |
|
Invention
|
Maleate salts of (e)-n-{4[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-... |
2016
|
Invention
|
Antineoplastic combinations containing hki-272 and vinorelbine. A combination of HKI-272 compound... |
|
Invention
|
Antibody-drug conjugates.
Disclosed are anti-5T4 antibody drug conjugates and methods for prepar... |